These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 32844483)
41. Differential Effects on Ocular Biometrics by 0.05%, 0.025%, and 0.01% Atropine: Low-Concentration Atropine for Myopia Progression Study. Li FF; Kam KW; Zhang Y; Tang SM; Young AL; Chen LJ; Tham CC; Pang CP; Yam JC Ophthalmology; 2020 Dec; 127(12):1603-1611. PubMed ID: 32525048 [TBL] [Abstract][Full Text] [Related]
42. Cost-effectiveness of cycloplegic agents: results of a randomized controlled trial in nigerian children. Ebri A; Kuper H; Wedner S Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1025-31. PubMed ID: 17325142 [TBL] [Abstract][Full Text] [Related]
43. Short-Term Effect of Low-Dose Atropine and Hyperopic Defocus on Choroidal Thickness and Axial Length in Young Myopic Adults. Sander BP; Collins MJ; Read SA J Ophthalmol; 2019; 2019():4782536. PubMed ID: 31531235 [TBL] [Abstract][Full Text] [Related]
44. [The cycloplegic effect of atropine in comparison with the cyclopentolate-tropicamide-phenylephrine combination]. Alimgil ML; Erda N Klin Monbl Augenheilkd; 1992 Jul; 201(1):9-11. PubMed ID: 1513131 [TBL] [Abstract][Full Text] [Related]
45. Choroidal Thickness and Peripheral Myopic Defocus during Orthokeratology. Gardner DJ; Walline JJ; Mutti DO Optom Vis Sci; 2015 May; 92(5):579-88. PubMed ID: 25875682 [TBL] [Abstract][Full Text] [Related]
46. Retinoscopy in infants using a near noncycloplegic technique, cycloplegia with tropicamide 1%, and cycloplegia with cyclopentolate 1%. Twelker JD; Mutti DO Optom Vis Sci; 2001 Apr; 78(4):215-22. PubMed ID: 11349929 [TBL] [Abstract][Full Text] [Related]
47. Topical atropine in retarding myopic progression and axial length growth in children with moderate to severe myopia: a pilot study. Fan DS; Lam DS; Chan CK; Fan AH; Cheung EY; Rao SK Jpn J Ophthalmol; 2007; 51(1):27-33. PubMed ID: 17295137 [TBL] [Abstract][Full Text] [Related]
48. [Cycloplegic effectiveness of cyclopentolate and tropicamide preparations compared with atropinization]. Proskurina OV Vestn Oftalmol; 2002; 118(6):42-5. PubMed ID: 12506660 [TBL] [Abstract][Full Text] [Related]
49. Short-term refractive change and ocular parameter changes after cycloplegia. Cheng HC; Hsieh YT Optom Vis Sci; 2014 Sep; 91(9):1113-7. PubMed ID: 25036542 [TBL] [Abstract][Full Text] [Related]
50. Changes in Choroidal Thickness Varied by Age and Refraction in Children and Adolescents: A 1-Year Longitudinal Study. Xiong S; He X; Zhang B; Deng J; Wang J; Lv M; Zhu J; Zou H; Xu X Am J Ophthalmol; 2020 May; 213():46-56. PubMed ID: 31945330 [TBL] [Abstract][Full Text] [Related]
51. Age dependence of ocular biometric measurements under cycloplegia with tropicamide and cyclopentolate. Owens H; Garner LF; Yap MK; Frith MJ; Kinnear RF Clin Exp Optom; 1998; 81(4):159-162. PubMed ID: 12482253 [TBL] [Abstract][Full Text] [Related]
52. Association of refraction and ocular biometry in highly myopic eyes. Chen Y; Wang D; Chen L; Yan W; He M Clin Exp Optom; 2021 Jul; 104(5):589-594. PubMed ID: 33689619 [No Abstract] [Full Text] [Related]
53. Accuracy of Noncycloplegic Refraction for Detecting Refractive Errors in School-aged African Children. Ilechie AA; Addo NA; Abraham CH; Owusu-Ansah A; Annan-Prah A Optom Vis Sci; 2021 Aug; 98(8):920-928. PubMed ID: 34460453 [TBL] [Abstract][Full Text] [Related]
54. A randomized clinical trial using atropine, cyclopentolate, and tropicamide to compare refractive outcome in hypermetropic children with a dark iris; skin pigmentation and crying as significant factors for hypermetropic outcome. van Minderhout HM; Joosse MV; Grootendorst DC; Schalij-Delfos NE Strabismus; 2019 Sep; 27(3):127-138. PubMed ID: 31234691 [No Abstract] [Full Text] [Related]
55. A Clinical Randomized Trial Comparing the Cycloplegic Effect of Cyclopentolate Drops Applied to Closed Eyelids Versus Open Eyelids. Zurevinsky J; Sawchuk K; Lim HJ; Lee CH; Rubab S Am Orthopt J; 2016 Jan; 66(1):114-121. PubMed ID: 27799585 [TBL] [Abstract][Full Text] [Related]
56. A comparison of autorefraction and subjective refraction with and without cycloplegia in primary school children. Choong YF; Chen AH; Goh PP Am J Ophthalmol; 2006 Jul; 142(1):68-74. PubMed ID: 16815252 [TBL] [Abstract][Full Text] [Related]
57. A retrospective analysis of the therapeutic effects of 0.01% atropine on axial length growth in children in a real-life clinical setting. Kaymak H; Graff B; Schaeffel F; Langenbucher A; Seitz B; Schwahn H Graefes Arch Clin Exp Ophthalmol; 2021 Oct; 259(10):3083-3092. PubMed ID: 34142186 [TBL] [Abstract][Full Text] [Related]
58. Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (Atropine for the Treatment of Myopia 2). Chia A; Chua WH; Cheung YB; Wong WL; Lingham A; Fong A; Tan D Ophthalmology; 2012 Feb; 119(2):347-54. PubMed ID: 21963266 [TBL] [Abstract][Full Text] [Related]
59. [Research of cyclopentolate 1% on the effect of cycloplegia for Chinese hyperopic children]. Wang XM; Ma LX; Wang LH Zhonghua Yan Ke Za Zhi; 2011 Nov; 47(11):989-94. PubMed ID: 22336064 [TBL] [Abstract][Full Text] [Related]
60. Low-dose (0.01%) atropine eye-drops to reduce progression of myopia in children: a multicentre placebo-controlled randomised trial in the UK (CHAMP-UK)-study protocol. Azuara-Blanco A; Logan N; Strang N; Saunders K; Allen PM; Weir R; Doherty P; Adams C; Gardner E; Hogg R; McFarland M; Preston J; Verghis R; Loughman JJ; Flitcroft I; Mackey DA; Lee SS; Hammond C; Congdon N; Clarke M Br J Ophthalmol; 2020 Jul; 104(7):950-955. PubMed ID: 31653669 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]